Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_provenance.
- NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_assertion description "[Because ASXL1 lesions have been increasingly identified in myeloid neoplasms, we examined the relationships of ASXL1 mutation or deletion to both clinical phenotype and associated molecular features in 166 patients with myeloproliferative neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_provenance.
- NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_assertion evidence source_evidence_literature NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_provenance.
- NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_assertion SIO_000772 21712540 NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_provenance.
- NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_assertion wasDerivedFrom befree-20140225 NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_provenance.
- NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_assertion wasGeneratedBy ECO_0000203 NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_provenance.
- befree-20140225 importedOn "2014-02-25" NP255032.RAJK4cOfcT9Vo3Fp9cZcPUa66J_h5WxcdHD-4b-bX_E00130_provenance.